150 related articles for article (PubMed ID: 20153822)
21. The spectrum of clinical disease caused by the A467T and W748S POLG mutations: a study of 26 cases.
Tzoulis C; Engelsen BA; Telstad W; Aasly J; Zeviani M; Winterthun S; Ferrari G; Aarseth JH; Bindoff LA
Brain; 2006 Jul; 129(Pt 7):1685-92. PubMed ID: 16638794
[TBL] [Abstract][Full Text] [Related]
22. Functional defects due to spacer-region mutations of human mitochondrial DNA polymerase in a family with an ataxia-myopathy syndrome.
Luoma PT; Luo N; Löscher WN; Farr CL; Horvath R; Wanschitz J; Kiechl S; Kaguni LS; Suomalainen A
Hum Mol Genet; 2005 Jul; 14(14):1907-20. PubMed ID: 15917273
[TBL] [Abstract][Full Text] [Related]
23. Analysis of mutant DNA polymerase gamma in patients with mitochondrial DNA depletion.
Taanman JW; Rahman S; Pagnamenta AT; Morris AA; Bitner-Glindzicz M; Wolf NI; Leonard JV; Clayton PT; Schapira AH
Hum Mutat; 2009 Feb; 30(2):248-54. PubMed ID: 18828154
[TBL] [Abstract][Full Text] [Related]
24. Multiple regions of subunit interaction in Drosophila mitochondrial DNA polymerase: three functional domains in the accessory subunit.
Fan L; Kaguni LS
Biochemistry; 2001 Apr; 40(15):4780-91. PubMed ID: 11294646
[TBL] [Abstract][Full Text] [Related]
25. The mitochondrial p55 accessory subunit of human DNA polymerase gamma enhances DNA binding, promotes processive DNA synthesis, and confers N-ethylmaleimide resistance.
Lim SE; Longley MJ; Copeland WC
J Biol Chem; 1999 Dec; 274(53):38197-203. PubMed ID: 10608893
[TBL] [Abstract][Full Text] [Related]
26. mip1 containing mutations associated with mitochondrial disease causes mutagenesis and depletion of mtDNA in Saccharomyces cerevisiae.
Stumpf JD; Bailey CM; Spell D; Stillwagon M; Anderson KS; Copeland WC
Hum Mol Genet; 2010 Jun; 19(11):2123-33. PubMed ID: 20185557
[TBL] [Abstract][Full Text] [Related]
27. Functional human mitochondrial DNA polymerase gamma forms a heterotrimer.
Yakubovskaya E; Chen Z; Carrodeguas JA; Kisker C; Bogenhagen DF
J Biol Chem; 2006 Jan; 281(1):374-82. PubMed ID: 16263719
[TBL] [Abstract][Full Text] [Related]
28. Molecular diagnosis of Alpers syndrome.
Nguyen KV; Sharief FS; Chan SS; Copeland WC; Naviaux RK
J Hepatol; 2006 Jul; 45(1):108-16. PubMed ID: 16545482
[TBL] [Abstract][Full Text] [Related]
29. POLG mutations in neurodegenerative disorders with ataxia but no muscle involvement.
Van Goethem G; Luoma P; Rantamäki M; Al Memar A; Kaakkola S; Hackman P; Krahe R; Löfgren A; Martin JJ; De Jonghe P; Suomalainen A; Udd B; Van Broeckhoven C
Neurology; 2004 Oct; 63(7):1251-7. PubMed ID: 15477547
[TBL] [Abstract][Full Text] [Related]
30. Mitochondrial DNA polymerase-gamma and human disease.
Hudson G; Chinnery PF
Hum Mol Genet; 2006 Oct; 15 Spec No 2():R244-52. PubMed ID: 16987890
[TBL] [Abstract][Full Text] [Related]
31. Biochemical analysis of human POLG2 variants associated with mitochondrial disease.
Young MJ; Longley MJ; Li FY; Kasiviswanathan R; Wong LJ; Copeland WC
Hum Mol Genet; 2011 Aug; 20(15):3052-66. PubMed ID: 21555342
[TBL] [Abstract][Full Text] [Related]
32. Structural insight into processive human mitochondrial DNA synthesis and disease-related polymerase mutations.
Lee YS; Kennedy WD; Yin YW
Cell; 2009 Oct; 139(2):312-24. PubMed ID: 19837034
[TBL] [Abstract][Full Text] [Related]
33. Abundance of the POLG disease mutations in Europe, Australia, New Zealand, and the United States explained by single ancient European founders.
Hakonen AH; Davidzon G; Salemi R; Bindoff LA; Van Goethem G; Dimauro S; Thorburn DR; Suomalainen A
Eur J Hum Genet; 2007 Jul; 15(7):779-83. PubMed ID: 17426723
[TBL] [Abstract][Full Text] [Related]
34. Mitochondrial DNA defects in Saccharomyces cerevisiae caused by functional interactions between DNA polymerase gamma mutations associated with disease in human.
Baruffini E; Ferrero I; Foury F
Biochim Biophys Acta; 2007 Dec; 1772(11-12):1225-35. PubMed ID: 17980715
[TBL] [Abstract][Full Text] [Related]
35. Clustering of Alpers disease mutations and catalytic defects in biochemical variants reveal new features of molecular mechanism of the human mitochondrial replicase, Pol γ.
Euro L; Farnum GA; Palin E; Suomalainen A; Kaguni LS
Nucleic Acids Res; 2011 Nov; 39(21):9072-84. PubMed ID: 21824913
[TBL] [Abstract][Full Text] [Related]
36. POLG mutations and Alpers syndrome.
Davidzon G; Mancuso M; Ferraris S; Quinzii C; Hirano M; Peters HL; Kirby D; Thorburn DR; DiMauro S
Ann Neurol; 2005 Jun; 57(6):921-3. PubMed ID: 15929042
[TBL] [Abstract][Full Text] [Related]
37. Pure Progressive Ataxia and Palatal Tremor (PAPT) Associated with a New Polymerase Gamma (POLG) Mutation.
Nicastro N; Ranza E; Antonarakis SE; Horvath J
Cerebellum; 2016 Dec; 15(6):829-831. PubMed ID: 26607151
[TBL] [Abstract][Full Text] [Related]
38. Association of novel POLG mutations and multiple mitochondrial DNA deletions with variable clinical phenotypes in a Spanish population.
González-Vioque E; Blázquez A; Fernández-Moreira D; Bornstein B; Bautista J; Arpa J; Navarro C; Campos Y; Fernández-Moreno MA; Garesse R; Arenas J; Martín MA
Arch Neurol; 2006 Jan; 63(1):107-11. PubMed ID: 16401742
[TBL] [Abstract][Full Text] [Related]
39. Rapidly progressive neurological deterioration in a child with Alpers syndrome exhibiting a previously unremarkable brain MRI.
Brunetti-Pierri N; Selby K; O'Sullivan M; Hendson G; Truong C; Waters PJ; Wong LJ
Neuropediatrics; 2008 Jun; 39(3):179-83. PubMed ID: 18991199
[TBL] [Abstract][Full Text] [Related]
40. Infantile-onset spinocerebellar ataxia and mitochondrial recessive ataxia syndrome are associated with neuronal complex I defect and mtDNA depletion.
Hakonen AH; Goffart S; Marjavaara S; Paetau A; Cooper H; Mattila K; Lampinen M; Sajantila A; Lönnqvist T; Spelbrink JN; Suomalainen A
Hum Mol Genet; 2008 Dec; 17(23):3822-35. PubMed ID: 18775955
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
